The Recombinant Drosophila erecta Adenosine Monophosphate-Protein Transferase FICD Homolog (GG10411) is a recombinant protein derived from the fruit fly Drosophila erecta. This protein is homologous to the human FICD (Filamentation induced by cAMP domain) protein, which plays a crucial role in the adenylylation and deadenylylation of proteins, impacting cellular processes such as protein function and stability.
Species: Drosophila erecta (Fruit fly)
Source: Expressed in Escherichia coli (E. coli)
Tag: N-terminal His tag
Protein Length: Full length, spanning 1-495 amino acids
Form: Lyophilized powder
Purity: Greater than 90% as determined by SDS-PAGE
Amino Acid Sequence: The protein sequence begins with MGTEAEPPSPPSPPAQQQEQANPPVWNAQNQKPARLYRLVLFFIAGSLTAWMFHAFSSSNLAWKLRQLHHLPTAHYLQTRDEFALYSVEELNAFKEFYDKSVSDSVGASFTEAEQTSINEALVSLRMAQDMYLTGKDDKAARLFEHALALAPRHPEVLLRYGEFLEHNQRNIVLADQYYFQALTISPSNSEALANRQRTADVVQNLDQRRLESLDSKRDALSAIHESNAALRRAKKEAYFQHIYHSVGIEGNTMTLAQTRSILETRMAVDGKSIDEHNEILGMDLAMKYINASLVQKIEITIKDILELHRRVMGHVDPIEGGEFRRNQVYVGGHIPPGPGDLALLMQRFERWLNSEHISTLHPVNYAALAHYKLVHIHPFIDGNGRTSRLLMNTLLMRAGYPPVIIPKQQRSKYYHFLKLANGE DIRPFVRFIADCTEKTLDLYLWATSDLPQQIPMLIQTESEAGERLAQMQSPNVAQRSSILEFYESGSGALP .
Gene Name: GG10411
Synonyms: GG10411; Protein adenylyltransferase Fic; De-AMPylase Fic
UniProt ID: B3N5J3
This protein functions as a dual-acting enzyme, mediating both the addition (AMPylation) and removal (de-AMPylation) of adenosine 5'-monophosphate (AMP) to/from target proteins. The Glu-250 residue dictates whether AMPylation or de-AMPylation occurs. It plays a crucial regulatory role in the unfolded protein response (UPR) by modulating the AMPylation/de-AMPylation of Hsc70-3/BiP. Under normal cellular conditions, it functions as an adenylyltransferase, AMPylating Hsc70-3/BiP at Thr-518, leading to inactivation. In response to endoplasmic reticulum stress, it acts as a phosphodiesterase, removing AMP from Hsc70-3/BiP at Thr-518, thus restoring HSPA5/BiP activity.
KEGG: der:Dere_GG10411
What is Drosophila erecta Adenosine monophosphate-protein transferase FICD homolog (GG10411)?
Drosophila erecta Adenosine monophosphate-protein transferase FICD homolog (GG10411) is a full-length protein found in D. erecta fruit flies that functions as an adenosine monophosphate-protein transferase. It belongs to the FICD (FIC domain-containing) protein family, which is involved in post-translational modification of target proteins through AMPylation (the addition of AMP to proteins). The protein has 495 amino acids and shares significant sequence homology with FICD proteins in other Drosophila species such as D. willistoni and D. yakuba . Functionally, it may play roles in cellular stress responses, protein homeostasis, and potentially lifespan regulation through connections to AMP-related metabolic pathways.
How does GG10411 compare to FICD homologs in other Drosophila species?
GG10411 in D. erecta shares significant sequence conservation with FICD homologs in other Drosophila species, though with species-specific variations. The protein has 495 amino acids, compared to 498 in D. willistoni (GK14760) and 495 in D. yakuba (GE13868) . Sequence analysis shows conserved functional domains across species, particularly in the catalytic core regions responsible for AMPylation activity. The conservation pattern suggests evolutionary pressure to maintain FICD functionality while allowing some adaptation to species-specific requirements. Cross-species comparative analysis provides insights into which protein regions are most critical for function versus those that may be involved in species-specific adaptations of the protein.
What expression systems are typically used for producing recombinant GG10411?
Recombinant GG10411 is typically produced in prokaryotic expression systems, predominantly E. coli, similar to the approach used for other Drosophila FICD homologs . The standard methodology involves:
Cloning the full-length gene (coding for amino acids 1-495) into a suitable expression vector
Adding an N-terminal His-tag for purification purposes
Expression in E. coli under optimized conditions
Purification using affinity chromatography
Final preparation as a lyophilized powder for storage stability
The purified protein typically achieves >90% purity as confirmed by SDS-PAGE analysis. Alternative expression systems such as yeast or insect cells may be considered for specific research applications requiring eukaryotic post-translational modifications, though these are less commonly used for basic functional studies.
What are the optimal storage and handling conditions for recombinant GG10411?
For optimal stability and functionality of recombinant GG10411, follow these evidence-based storage and handling protocols:
| Condition | Recommendation | Rationale |
|---|---|---|
| Storage form | Lyophilized powder | Maximizes stability |
| Storage temperature | -20°C to -80°C | Prevents degradation |
| Buffer composition | Tris/PBS-based buffer with 6% Trehalose, pH 8.0 | Maintains protein integrity |
| Reconstitution | Deionized sterile water to 0.1-1.0 mg/mL | Optimal concentration range |
| Long-term storage | Add glycerol to 5-50% final concentration | Prevents freeze damage |
| Working aliquots | Store at 4°C for up to one week | Minimizes freeze-thaw cycles |
Avoid repeated freeze-thaw cycles as they significantly reduce protein activity. After reconstitution, aliquot the protein and store unused portions at -80°C. When working with the protein, maintain cold chain integrity and use fresh aliquots for critical experiments .
What assays are recommended for confirming the enzymatic activity of GG10411?
To confirm the enzymatic activity of GG10411 as an adenosine monophosphate-protein transferase, researchers should employ a multi-faceted approach:
Primary activity assay: Monitor AMP transfer to target proteins using radiolabeled ATP (α-32P-ATP) followed by SDS-PAGE separation and autoradiography
Mass spectrometry validation: Identify AMPylated substrates and specific modification sites using high-resolution MS/MS analysis
Phosphorimaging quantification: Measure modification stoichiometry and enzyme kinetics
In vitro substrate screening: Test candidate proteins for modification, focusing on endoplasmic reticulum chaperones like BiP/GRP78 as these are common FICD targets
AMPylation-specific antibodies: Use antibodies recognizing AMP modifications for western blotting
Site-directed mutagenesis controls: Include catalytically inactive mutants (typically histidine to alanine mutations in the FIC domain) as negative controls
These complementary approaches provide comprehensive validation of enzymatic activity and substrate specificity .
How can I design experiments to investigate GG10411's role in lifespan regulation?
When investigating GG10411's potential role in lifespan regulation, design your experiments based on established connections between AMP biosynthesis, AMPK signaling, and Drosophila longevity:
Genetic manipulation approaches:
Generate D. erecta transgenic lines with GG10411 overexpression or knockdown
Create heterozygous mutations in GG10411 to examine partial loss-of-function effects
Use tissue-specific drivers (especially fat body and muscle) for targeted expression
Lifespan analysis protocols:
Measure adult lifespan curves under standard conditions
Test survival under various stressors (oxidative, thermal, starvation)
Compare effects in different genetic backgrounds
Metabolic measurements:
Quantify AMP:ATP and ADP:ATP ratios using HPLC
Measure AMPK activation (phosphorylation status)
Assess energy metabolism markers
Dietary manipulations:
Test effects of adenine supplementation
Combine with dietary restriction protocols
Examine interactions with known lifespan-extending interventions
This experimental framework leverages the established connection between adenosine nucleotide metabolism and Drosophila lifespan regulation . Focus measurements on metabolic tissues (fat body and muscle) where AMPK expression has demonstrated lifespan effects.
How do research approaches differ when investigating post-translational modifications by GG10411 versus its role in reproductive biology?
Research investigating GG10411 demonstrates distinct methodological approaches depending on whether the focus is post-translational modifications or reproductive biology:
| Research Focus | Post-translational Modifications | Reproductive Biology |
|---|---|---|
| Primary techniques | Biochemical assays, mass spectrometry, protein interaction studies | Genetic crosses, morphological analyses, behavioral assays |
| Model systems | Cell-free systems, cell culture, whole organism | Whole organism, population studies |
| Key measurements | Enzyme kinetics, substrate specificity, modification sites | Fertility rates, reproductive success, genital morphology |
| Genetic approaches | Site-directed mutagenesis of catalytic residues | Analysis of natural variation, genetic crosses |
| Time scale | Hours to days (enzymatic reactions) | Generations (evolutionary studies) |
| Relevant contexts | Cellular stress, protein homeostasis | Sexual selection, mating behavior, species isolation |
While studying enzymatic functions requires biochemical and proteomic approaches, reproductive biology investigations necessitate evolutionary and ecological perspectives, particularly considering D. erecta's unique genital morphology that influences reproductive success . Researchers should adjust experimental design accordingly, potentially examining how GG10411-mediated protein modifications might influence reproductive tissues or processes.
What are the methodological challenges in studying the evolutionary conservation of GG10411 across different Drosophila species?
Studying the evolutionary conservation of GG10411 across Drosophila species presents several methodological challenges that require specific technical approaches:
Sequence divergence handling:
Use progressive multiple sequence alignment algorithms with sensitivity for divergent sequences
Employ structure-guided alignments when sequence identity falls below 40%
Implement phylogeny-aware gap penalties in alignments
Functional conservation assessment:
Develop cross-species complementation assays
Use domain-swapping experiments to identify functionally conserved regions
Test substrate specificity across orthologs
Evolutionary rate analysis:
Calculate dN/dS ratios to identify selection pressures
Use branch-site models to detect lineage-specific selection
Analyze coevolution between FICD and its substrates
Tissue-specific expression profiling:
Compare expression patterns across species using RNA-seq
Develop cross-reactive antibodies targeting conserved epitopes
Use reporter constructs with orthologous promoters
Structural biology challenges:
Express and purify orthologs using standardized protocols for comparison
Perform comparative structural analysis (X-ray crystallography or cryo-EM)
Model species-specific protein-substrate interactions
These approaches help overcome the challenges posed by sequence divergence, structural variations, and different evolutionary pressures across Drosophila species .
What techniques can effectively assess the interaction between GG10411 and transposable element activity in D. erecta?
To effectively assess potential interactions between GG10411 and transposable element activity in D. erecta, researchers should implement a multi-layered experimental approach:
Genomic analysis:
Map P-element insertions relative to GG10411 loci using ONT long-read sequencing
Track population frequencies of insertions across generations
Analyze chromatin accessibility around GG10411 in response to P-element invasion
Small RNA profiling:
Sequence and analyze piRNA and siRNA populations targeting P-elements
Compare small RNA profiles between wild-type and GG10411 mutant backgrounds
Assess maternal deposition of regulatory RNAs
Transcriptome analysis:
Monitor expression changes of GG10411 during P-element invasion
Analyze splicing patterns of P-element transcripts
Perform stranded RNA-Seq at regular generational intervals
Functional genetics:
Create GG10411 knockdown/overexpression lines to test effects on transposon silencing
Assess transgenerational effects through carefully controlled genetic crosses
Identify genetic interactions with known piRNA pathway components
This approach combines genomic, transcriptomic, and genetic techniques to comprehensively assess the relationship between GG10411 activity and transposable element regulation in experimental populations .
How can I develop an experimental system to test whether GG10411 influences the morphology of male genitalia in D. erecta?
To investigate GG10411's potential role in D. erecta male genital morphology, develop an experimental system that integrates developmental genetics with morphological analysis:
Genetic manipulation strategies:
Generate CRISPR/Cas9 knockouts or hypomorphic alleles of GG10411
Create tissue-specific knockdown using RNAi driven by genital disc-specific GAL4 drivers
Develop temperature-sensitive conditional alleles for temporal control
Developmental analysis:
Perform immunohistochemistry on pupal genitalia using anti-E-cadherin to visualize apical cell junctions
Compare developmental trajectories between wild-type and GG10411-modified backgrounds
Track the development of specific structures like the postgonal process and aedeagus
Morphometric analysis:
Use confocal microscopy to image adult male genitalia
Implement geometric morphometrics for quantitative shape analysis
Compare three-dimensional structure of processes using micro-CT scanning
Functional assessment:
Conduct mating assays to assess reproductive success
Examine physical interaction with female genitalia
Analyze potential relationships to copulatory wounding
This experimental system enables comprehensive analysis of how GG10411-mediated processes influence the development and final morphology of male genital structures, with particular attention to the complex three-dimensional nature of phallic processes that are critical for reproductive success in D. erecta .
What are the best approaches for investigating potential links between GG10411, AMP biosynthesis, and stress response in D. erecta?
To investigate the relationship between GG10411, AMP biosynthesis, and stress response in D. erecta, implement these evidence-based approaches:
Metabolomic profiling:
Quantify adenine nucleotide pools (AMP, ADP, ATP) using targeted LC-MS/MS
Measure AMP:ATP ratios under normal and stress conditions
Track metabolic changes during stress recovery in wild-type vs. GG10411 mutant backgrounds
AMPK signaling analysis:
Assess AMPK phosphorylation status using phospho-specific antibodies
Monitor downstream targets of AMPK activation
Compare signaling dynamics between control and GG10411-modified flies
Stress resistance assays:
Subject flies to oxidative stress (paraquat, H₂O₂)
Apply thermal stress protocols (heat shock)
Conduct starvation resistance tests
Compare survival curves between experimental groups
Gene expression analysis:
Perform RNA-seq under normal and stress conditions
Analyze expression of stress response genes
Compare transcriptional profiles between tissue types (fat body vs. muscle)
Dietary manipulation:
Supplement diet with adenine to modify AMP biosynthesis
Combine with GG10411 genetic manipulation
Test interactions with dietary restriction protocols
These approaches provide a comprehensive assessment of GG10411's potential role in connecting AMP metabolism to stress response mechanisms, building on established connections between adenosine nucleotide ratios and stress resistance in Drosophila .
What controls and validation methods should be employed when studying the AMPylation activity of GG10411 in Drosophila tissues?
When studying the AMPylation activity of GG10411 in Drosophila tissues, implement these critical controls and validation methods:
Enzymatic controls:
Catalytic-dead mutant: Generate a histidine-to-alanine mutation in the FIC domain catalytic site as a negative control
Positive control: Include a well-characterized FICD protein from another species with established activity
Substrate controls: Test known FICD substrates (e.g., BiP/Hsp70 family proteins) alongside experimental targets
Tissue-specific validation:
Tissue preparation controls: Compare fresh vs. fixed tissues to account for post-mortem modification changes
Subcellular fractionation: Validate activity in relevant compartments (typically ER-enriched fractions)
Cell type-specific analysis: Use FACS-sorted cells or single-cell approaches for heterogeneous tissues
Analytical validation:
Multiple detection methods: Combine radioactive labeling, anti-AMP antibodies, and mass spectrometry
Site-mapping confirmation: Verify modification sites by MS/MS and site-directed mutagenesis of substrate residues
Quantitative standards: Include known quantities of synthetically AMPylated peptides as standards
Physiological relevance:
Stress induction: Compare AMPylation profiles under normal vs. stress conditions
Developmental timing: Assess activity across developmental stages
In vivo vs. in vitro correlation: Validate that in vitro findings reflect in vivo modification patterns
These rigorous controls and validation methods ensure specific attribution of AMPylation activity to GG10411 rather than other enzymes or artifacts, establishing confidence in the biological significance of findings.